These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9600702)

  • 1. Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis.
    Ossege LM; Sindern E; Voss B; Malin JP
    J Neuroimmunol; 1998 Apr; 84(1):1-6. PubMed ID: 9600702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta1 (TGFbeta1) mRNA level correlates with magnetic resonance imaging disease activity in multiple sclerosis patients.
    Bertolotto A; Capobianco M; Malucchi S; Manzardo E; Audano L; Bergui M; Bradac GB; Mutani R
    Neurosci Lett; 1999 Mar; 263(1):21-4. PubMed ID: 10218901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.
    Navikas V; Matusevicius D; Söderström M; Pirskanen R; Fredrikson S; Link H
    Clin Neuropharmacol; 1998; 21(4):236-44. PubMed ID: 9704165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
    Monteyne P; Van Antwerpen MP; Sindic CJ
    Acta Neurol Belg; 1999 Mar; 99(1):11-20. PubMed ID: 10218088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of IFNbeta1b treatment on the spontaneous and induced expression of IL-10 and TGFbeta1 in MS patients.
    Gayo A; Mozo L; Suárez A; Tuñon A; Lahoz C; Gutiérrez C
    J Neurol Sci; 2000 Oct; 179(S 1-2):43-9. PubMed ID: 11054484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR.
    Monteyne P; Sindic CJ
    Mult Scler; 1998 Jun; 4(3):143-6. PubMed ID: 9762664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
    Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
    Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of IFN-gamma, IL-4, and TGF-beta in multiple sclerosis in relation to HLA-Dw2 phenotype and stage of disease.
    Söderström M; Hillert J; Link J; Navikas V; Fredrikson S; Link H
    Mult Scler; 1995 Nov; 1(3):173-80. PubMed ID: 9345450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis.
    Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Poser S
    Neurology; 1994 Aug; 44(8):1523-6. PubMed ID: 8058164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Establishment of a method for detecting transforming growth factor beta 1 mRNA].
    Chen F; Cai W; Chen Z; Liu R
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(3):219-22. PubMed ID: 12078246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo effects of mitoxantrone on the production of pro- and anti-inflammatory cytokines by peripheral blood mononuclear cells of secondary progressive multiple sclerosis patients.
    Angelucci F; Batocchi AP; Caggiula M; Frisullo G; Patanella K; Sancricca C; Nociti V; Tonali PA; Mirabella M
    Neuroimmunomodulation; 2006; 13(2):76-81. PubMed ID: 16974110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
    Malhotra S; Castilló J; Negrotto L; Merino-Zamorano C; Montaner J; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroimmunol; 2013 Aug; 261(1-2):146-8. PubMed ID: 23796873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine mRNA expression in CSF and peripheral blood mononuclear cells in multiple sclerosis: detection by RT-PCR without in vitro stimulation.
    Monteyne P; Van Laere V; Marichal R; Sindic CJ
    J Neuroimmunol; 1997 Dec; 80(1-2):137-42. PubMed ID: 9413269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7-1 (CD80), B7-2 (CD86), interleukin-12 and transforming growth factor-beta mRNA expression in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.
    Monteyne P; Guillaume B; Sindic CJ
    J Neuroimmunol; 1998 Nov; 91(1-2):198-203. PubMed ID: 9846836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients.
    Di Paolo S; Schena A; Stallone G; Grandaliano G; Soccio M; Cerullo G; Gesualdo L; Paolo Schena F
    Transplantation; 2002 Dec; 74(12):1710-5. PubMed ID: 12499886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Change of transforming growth factor beta in peripheral blood mononuclear cell of children with nephrotic syndrome and its significance].
    Yu L; Weng ZY; Zhong ZM; Zeng CH; Zhang YX; Zhuo MY
    Zhonghua Er Ke Za Zhi; 2003 Jul; 41(7):534-7. PubMed ID: 14746683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes.
    Leussink VI; Jung S; Merschdorf U; Toyka KV; Gold R
    Arch Neurol; 2001 Jan; 58(1):91-7. PubMed ID: 11176941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.
    Rieckmann P; Albrecht M; Kitze B; Weber T; Tumani H; Broocks A; Lüer W; Helwig A; Poser S
    Ann Neurol; 1995 Jan; 37(1):82-8. PubMed ID: 7818262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
    Feng X; Petraglia AL; Chen M; Byskosh PV; Boos MD; Reder AT
    J Neuroimmunol; 2002 Aug; 129(1-2):205-15. PubMed ID: 12161037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.